1. Home
  2. NATL vs TARS Comparison

NATL vs TARS Comparison

Compare NATL & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NCR Atleos Corporation

NATL

NCR Atleos Corporation

SELL

Current Price

$47.08

Market Cap

3.4B

Sector

N/A

ML Signal

SELL

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$72.39

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NATL
TARS
Founded
2023
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.6B
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
NATL
TARS
Price
$47.08
$72.39
Analyst Decision
Hold
Strong Buy
Analyst Count
3
10
Target Price
$50.20
★ $99.80
AVG Volume (30 Days)
★ 750.1K
648.3K
Earning Date
11-04-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 73.98
48.21
EPS
★ 1.15
N/A
Revenue
★ $4,354,000,000.00
$451,360,000.00
Revenue This Year
$2.59
$61.17
Revenue Next Year
$4.15
$26.47
P/E Ratio
$40.70
★ N/A
Revenue Growth
0.86
★ 146.71
52 Week Low
$33.31
$53.89
52 Week High
$48.50
$91.53

Technical Indicators

Market Signals
Indicator
NATL
TARS
Relative Strength Index (RSI) 63.83 47.96
Support Level $45.40 $60.95
Resistance Level $48.23 $73.45
Average True Range (ATR) 0.48 3.16
MACD 0.17 -0.24
Stochastic Oscillator 92.62 50.40

Price Performance

Historical Comparison
NATL
TARS

About NATL NCR Atleos Corporation

NCR Atleos Corp is a financial technology company providing self-directed banking solutions to a customer base including financial institutions, merchants, manufacturers, retailers, and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels, all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware, and its proprietary Allpoint network. Atleos manages its operations in the following segments: Self-Service Banking, which generates maximum revenue, Network, and Telecommunications and Technology. Geographically, it derives maximum revenue from the U.S.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

Share on Social Networks: